Treatment with ulipristal acetate (Esmya(®)) and plasma levels of tacrolimus: a case report

Eur J Obstet Gynecol Reprod Biol. 2016 Aug:203:337-8. doi: 10.1016/j.ejogrb.2016.05.014. Epub 2016 May 20.

Authors

Luis Fernández de Castillo Torras¹, Alex Biterna Tejeiro², M Jesús Pla Farnós², Jordi Ponce Sebastià²

Affiliations

¹ Department of Gynecology, University Hospital of Bellvitge, Barcelona, Spain. Electronic address: lfernandezdecastillo@bellvitgehospital.cat.
² Department of Gynecology, University Hospital of Bellvitge, Barcelona, Spain.

PMID: 27282803
DOI: 10.1016/j.ejogrb.2016.05.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Cholangitis / surgery
Drug Interactions
Female
Humans
Hysterectomy
Immunosuppressive Agents / blood*
Immunosuppressive Agents / therapeutic use
Leiomyomatosis / diagnostic imaging
Leiomyomatosis / drug therapy*
Leiomyomatosis / surgery
Liver Transplantation
Mycophenolic Acid / therapeutic use
Norpregnadienes / therapeutic use*
Tacrolimus / blood*
Tacrolimus / therapeutic use
Treatment Outcome
Uterine Neoplasms / diagnostic imaging
Uterine Neoplasms / drug therapy*
Uterine Neoplasms / surgery

Substances

Immunosuppressive Agents
Norpregnadienes
Mycophenolic Acid
Tacrolimus
ulipristal acetate